Literature DB >> 27749014

Society for Endocrinology UK guidance on the evaluation of suspected disorders of sexual development: emphasizing the opportunity to predict adolescent pubertal failure through a neonatal diagnosis of absent minipuberty.

Richard Quinton1,2, Yaasir Mamoojee2, Channa N Jayasena3, Jacques Young4, Sasha Howard5, Leo Dunkel5, Tim Cheetham1,6, Neil Smith7, Andrew A Dwyer8,9.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27749014     DOI: 10.1111/cen.13257

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  5 in total

1.  Safety and tolerability of one-year intramuscular testosterone regime to induce puberty in older men with CHH.

Authors:  Agnieszka Pazderska; Yaasir Mamoojee; Satish Artham; Margaret Miller; Stephen G Ball; Tim Cheetham; Richard Quinton
Journal:  Endocr Connect       Date:  2018-01       Impact factor: 3.335

2.  Minipuberty of human infancy - A window of opportunity to evaluate hypogonadism and differences of sex development?

Authors:  Christoffer Højrup Renault; Lise Aksglaede; Ditte Wøjdemann; Anna Berg Hansen; Rikke Beck Jensen; Anders Juul
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-06-30

Review 3.  Up-To-Date Review About Minipuberty and Overview on Hypothalamic-Pituitary-Gonadal Axis Activation in Fetal and Neonatal Life.

Authors:  Lucia Lanciotti; Marta Cofini; Alberto Leonardi; Laura Penta; Susanna Esposito
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-23       Impact factor: 5.555

Review 4.  Congenital Hypogonadotrophic Hypogonadism: Minipuberty and the Case for Neonatal Diagnosis.

Authors:  Du Soon Swee; Richard Quinton
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-21       Impact factor: 5.555

5.  Disorders of sex development: timing of diagnosis and management in a single large tertiary center.

Authors:  E Kohva; P J Miettinen; S Taskinen; M Hero; A Tarkkanen; T Raivio
Journal:  Endocr Connect       Date:  2018-03-26       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.